Clinical trials
Pathologic Complete Response trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Centre Leon Berard | 2 |
| AstraZeneca | 1 |
| Celgene | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| French Innovative Leukemia Organisation | 1 |
| GlaxoSmithKline | 1 |
| Institut Cancerologie de l'Ouest | 1 |
| Nantes University Hospital | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Complete Response | 17 |
| Leukemia, Myeloid, Acute | 3 |
| Rectal Neoplasms | 2 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 |
| Bone Neoplasms | 1 |
| Chondrosarcoma | 1 |
| Gastroenteritis | 1 |
| Hemangiosarcoma | 1 |
| Histiocytoma, Malignant Fibrous | 1 |
| Hypersensitivity | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.